Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Memphasys Ltd

MEM

ASX

Memphasys Limited (MEM) is an emerging small-cap reproductive biotechnology company on the rise in the field of fertility treatments. Founded in 2006, Memphasys Limited and its controlled entities are dedicated to developing and commercializing novel solutions for human and animal reproduction. Their focus lies on innovative technologies that address challenges in the area of fertility, aiming to improve success rates and broaden options for those seeking to conceive.

Latest Posts

Line Chart with Gradient
Price
$0.006
0.001 (9.09%)
At Close 22/11 (AEST)
Related Companies
SYNTARA LIMITED
$SNT
CANN GROUP LIMITED
$CAN
BCAL DIAGNOSTICS LIMITED
$BDX
MAYNE PHARMA GROUP LIMITED
$MYX
FIREBRICK PHARMA LIMITED
$FRE

Leave a Comment on MEM


Comments for MEM

    Latest Posts

    memphasys-asx-mem-advances-felix-system-clinical-trials-mem
    Health Care $MEM
    Memphasys (ASX: $MEM) advances felix system clinical trials95% patient recruitment completed, aiming for CE mark registration for European market entry
    November 18, 2024
    memphasys-asx-mem-successfully-raises-1-857-million-mem
    Health Care $MEM
    Memphasys (ASX: $MEM) successfully raises $1.857 millionFunds to boost reproductive biotechnology projects, including the Felix System
    November 5, 2024
    memphasys-asx-mem-advances-felix-system-clinical-trial-mem
    Health Care $MEM
    Memphasys (ASX: $MEM) advances Felix™ System clinical trialNear completion of trial, eyes CE mark registration for faster European market entry
    October 24, 2024
    memphasys-asx-mem-secures-short-term-loan-to-support-commercialisation-activities-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) secures short-term loan to support commercialisation activities

    Company secures $500,000 loan for key projects including clinical trial and equine fertility study

    September 17, 2024
    memphasys-asx-mem-progresses-equine-fertility-study-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) progresses equine fertility study

    Felix™ System shows potential in improving equine breeding outcomes

    September 16, 2024
    memphasys-asx-mem-raises-a2-0-million-for-felix-commercialisation-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) raises A$2.0 million for Felix™ commercialisation

    Placement and SPP to expedite strategic partner discussions and equine fertility study

    September 12, 2024
    memphasys-asx-mem-reinstatement-to-quotation-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) reinstatement to quotation

    Trading suspension lifted following capital raising announcement

    September 12, 2024
    memphasys-asx-mem-requests-voluntary-suspension-for-capital-raising-announcement-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) requests voluntary suspension for capital raising announcement

    Trading halt to be followed by voluntary suspension ahead of anticipated announcement

    September 11, 2024
    memphasys-asx-mem-requests-trading-halt-for-proposed-capital-raising-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) requests trading halt for proposed capital raising

    Trading halt requested to facilitate orderly market pending announcement

    September 9, 2024
    memphasys-asx-mem-commits-to-equine-fertility-study-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) commits to equine fertility study

    Three-year study to position Felix™ as leading technology for equine sperm selection

    September 4, 2024
    memphasys-asx-mem-outperforms-widely-used-sperm-preparation-method-in-japanese-clinical-trial-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) outperforms widely used sperm preparation method in Japanese clinical trial

    Felix™ System shows clear benefits over DGC+SU method in recent trial

    May 20, 2024
    memphasys-asx-mem-presents-investor-presentation-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) presents investor presentation

    Reproductive biotechnology company showcases diverse project pipeline and timelines

    May 10, 2024
    memphasys-asx-mem-accelerates-felix-system-sales-in-japan-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) accelerates felix™ system sales in japan

    Vitrolife places order for six additional consoles and 200 cartridges for Japanese IVF clinics

    March 18, 2024
    memphasys-asx-mem-raises-4-23-million-for-commercial-opportunities-and-pipeline-development-mem
    Health Care $MEM

    Memphasys (ASX: $MEM) raises $4.23 million for commercial opportunities and pipeline development

    Capital raising to pursue Felix™ opportunities and drive Product Development activities

    January 14, 2024
    memphasys-asxmem-raises-4-23-million-for-commercial-opportunities-and-pipeline-development-mem
    Health Care $MEM

    Memphasys (ASX:$MEM) raises $4.23 million for commercial opportunities and pipeline development

    Capital raising to pursue Felix™ opportunities and drive Product Development activities

    December 3, 2023

    MEM

    $MEM

    Memphasys (ASX: $MEM) advances felix system clinical trials

    95% patient recruitment completed, aiming for CE mark registration for European market entry

    MEM

    $MEM

    Memphasys (ASX: $MEM) successfully raises $1.857 million

    Funds to boost reproductive biotechnology projects, including the Felix System

    MEM

    $MEM

    Memphasys (ASX: $MEM) advances Felix™ System clinical trial

    Near completion of trial, eyes CE mark registration for faster European market entry

    MEM

    $MEM

    Memphasys (ASX: $MEM) secures short-term loan to support commercialisation activities

    Company secures $500,000 loan for key projects including clinical trial and equine fertility study

    MEM

    $MEM

    Memphasys (ASX: $MEM) progresses equine fertility study

    Felix™ System shows potential in improving equine breeding outcomes

    MEM

    $MEM

    Memphasys (ASX: $MEM) raises A$2.0 million for Felix™ commercialisation

    Placement and SPP to expedite strategic partner discussions and equine fertility study

    MEM

    $MEM

    Memphasys (ASX: $MEM) reinstatement to quotation

    Trading suspension lifted following capital raising announcement

    MEM

    $MEM

    Memphasys (ASX: $MEM) requests voluntary suspension for capital raising announcement

    Trading halt to be followed by voluntary suspension ahead of anticipated announcement

    MEM

    $MEM

    Memphasys (ASX: $MEM) requests trading halt for proposed capital raising

    Trading halt requested to facilitate orderly market pending announcement

    MEM

    $MEM

    Memphasys (ASX: $MEM) commits to equine fertility study

    Three-year study to position Felix™ as leading technology for equine sperm selection

    Load More
    No More Posts
    Related Companies
    WELLFULLY LIMITED
    $WFL
    DORSAVI LTD
    $DVL
    ARGENT BIOPHARMA LIMITED
    $RGT
    CSL LIMITED
    $CSL
    ADALTA LIMITED
    $1AD

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions